Post Hoc Analysis In Patients (Pts) With Unresectable Hepatocellular Carcinoma (Uhcc) Who Progressed To Child-Pugh B (Cpb) Liver Function In The Phase Iii Reflect Study Of Lenvatinib (Len).

298Background: The treatment landscape for pts with uHCC has recently expanded. However, there is an unmet need for effective treatment options in CPB pts. LEN is approved first-line in uHCC based ...